Gujarat Terce Laboratories Limited · BSE:GUJTERC
Gujarat Terce Laboratories — Q1 FY25 Earnings Presentation
16 slides from Gujarat Terce Laboratories's earnings presentation, Aug 9, 2024
Slide 1: BSE filing letter: Investor Presentation for quarter ended June 30, 2024
Date: 09-08-2024 To, Scrip Code: 524314 BSE Limited Security ID: GUJTERC Corporate Relation Department Phiroze ISIN: INE499G01013 Jeejeebhoy Towers, Dalai Streets, Mumbai- 400001, Maharashtra, India Dear Sir/Madam, Sub: Investors Presentation for Quarter ended on June 30,2024 Pursuant to Regulation
Slide 2: Gujarat Terce Laboratories Limited
\ GUJARAT TERCE 4 LABORATORIES LIMITED
Slide 3: Disclaimer
Disclaimer This presentation presentation is for for informational purposes only and and does not not constitute an an offer or ora a solicitation to sell or solicitation to or an an edition or or a a solicitation to submit an offer to purchase or subscribe for shares or securities of Gujarat Terce
Slide 4: Company Overview
Company Overview Gujarat Terce has over33 decades of of experience in the the Manufacturing and and Marketing of branded Generics. Generics. Roots of Gujarat Terce Laboratories Limited are entrenched in the the founding principles of COMPASSION and and EXCELLENCE. Terce has an extensive basket of 50
Slide 5: CEO Message
CEO Message To Our To Our Valued Shareholders, On On behalf of the entire team at at Gujarat Terce,I Terce, I am am pleased to share this update with you you as part of our our investor presentation. presentation. AA Strong Start to FY25 II am am delighted to report that our our Gujarat Terce busine
Slide 6: CEO Message
CEO Message To explain the To the strategic initiatives through the quarters quarters:: Trend of Parameters Over Time 1.S Q1 §j1 FY FY 24 24 Q2 g2 FY FY 24 24 Q3 /g3 FY FY 24 24 Q4 /g4 FY FY 24 24 Q1 $¡1 FY FY 25 25 Quarter @ Comsany Clcsinge Outstandingse Primary Secondary Stockist closing
Slide 7: CEO Message
CEO Message Key Key Strategic Initiatives and Their Impact initiatives and impact • Enhanced Collection Efficiency: Efficiency: • A A significant reduction in outstandings demonstrates successful efforts to improve collection processes, leading to enhanced cash flow and and reduced financial risk. r
Slide 8: CEO Message
CEO Message Our Our strategic focus onon secondary sales, improved financial management, and team development is driving strong results. results. We A We'veve achieved accelerated secondary sales growth, optimized inventory and and collections, and and empowered ourour team with brand-focused traini
Slide 9: Business Highlights
a a a Business I Highlights I I Figures= % /o of of total sales O Figures= O% of total sales /o of 100 100 62 62 79 79 81 81 83 83 Q1FY24 38 38 79 79 880 0 72 72 Acute Segment 61 61 Other Brands Q2FY24 39 39 60 60 Precious Brands Chronic Segment Q3FY24 40 40 28 28 60 60 21 21 19 19 21 21 Q4FY24 40 4
Slide 10: Business Highlights- PCPM (Per Capita Per Month)
Business Highlights- PCPM (Per Capita Per Month) 2.50 2.28 2.00 2.00 1.87 1.75 The strategic initiatives has The has started 1.54 showing resulting in ina a growing PCPM 1.50 and rationalised costs has andrationalised has brought the breakeven PCPM. 1.00 The Acute portfolio of the the corporate 0.50
Slide 11: Business Highlights- Sales of Top Four Brands
Business i Highlights- i i hts Sales of To Top Four Fo Brands ra Figures in in lacs 299 299 295 295 300 300 120 120 102 102 97 97 101 101 97 97 250 250 100 100 204 200 200 80 80 74 74 150 139 139 130 130 60 60 100 100 40 40 50 50 20 20 0 0 Q1FY24 Q1 FY24 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q1 FY25 Q1FY24 Q1
Slide 12: Business Highlights- Sales of Top Four Brands
Business i Highlights- i i hts Sales of To Top Four Fo Brands ra Figures in in lacs 77 96 96 80 80 100 100 86 86 84 84 62 62 80 80 60 60 70 70 63 63 60 60 37 40 30 30 25 25 40 40 20 20 20 20 0 0 Q1FY24 Q1 FY24 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q1 FY25 Q1FY24 Q1 FY24 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q1 FY25 The
Slide 13: Distribution Network & Region Wise Sales
Distribution ist° i Network etwo & Region i Wise iseSales North 26.1% 17 6 105 139 West 75 75 49.3% 12 1 18 1 3 Central 24.6% 24.ó% 1 Stockists/ Region-wise sales distribution(Q1FY25) Distributors
Slide 14: Financial Highlights- Q1 FY25
Financial Highlights- Q1 FY25 Q1FY25 FY25 11 % 114 % 95 % YoY growth Op revenue EBITDA PBT Gujarat Terce has grown by 11 % in Q1 FY 25 compared to Q1 FY24. Cash Profit registered by business has increased by 101 % in Q1 FY 25 compared to Q1 FY24.
Slide 15: Q1FY25- Income Statement
Q1FY25- Income Statement Q1 Q1 FY 25 vs. Q1 FY 25 Q1 FY 24 FY 24 Particulars Q1 Q1 (FY 25) (FY 25) Q1 Q1 (FY 24) ((% O /o Change) Revenue 1188.88 1071.71 1071.71 11% 11% EBITDA 15.12 -105.11 -105.11 114% EBITDA(% EBITDA( /o of Net Sales) O 1.27% 1.27 0 /o -9.81% O -9.8# /o PBT PBT -6.95 -130.75 95%
Slide 16: Thank you.
Thank you. Registered Office: Gujarat Terce Laboratories Limited, 122/2 Ravi Estate, Bileshwarpura, Chhatral, T.A.: Kalol, Gandhinagar, Gujarat 382729 Corporate office: D/ 801 - 802 & 1202, The First, Behind Keshavbaug Party Plot, Near Shivalik High- Street, Vastrapur, Ahmedabad, Gujarat 380015 Inve
Gujarat Terce Laboratories — Q1 FY25 Earnings Presentation on 6ix